HomeCompareMDCA vs JNJ

MDCA vs JNJ: Dividend Comparison 2026

MDCA yields 84.50% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDCA wins by $1.99M in total portfolio value
10 years
MDCA
MDCA
● Live price
84.50%
Share price
$5.42
Annual div
$4.58
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.02M
Annual income
$608,110.53
Full MDCA calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — MDCA vs JNJ

📍 MDCA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDCAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDCA + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDCA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDCA
Annual income on $10K today (after 15% tax)
$7,182.66/yr
After 10yr DRIP, annual income (after tax)
$516,893.95/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, MDCA beats the other by $512,856.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDCA + JNJ for your $10,000?

MDCA: 50%JNJ: 50%
100% JNJ50/50100% MDCA
Portfolio after 10yr
$1.03M
Annual income
$306,430.21/yr
Blended yield
29.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MDCA
No analyst data
Altman Z
1.1
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDCA buys
0
JNJ buys
0
No recent congressional trades found for MDCA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDCAJNJ
Forward yield84.50%2.14%
Annual dividend / share$4.58$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$2.02M$30.5K
Annual income after 10y$608,110.53$4,749.88
Total dividends collected$1.77M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MDCA vs JNJ ($10,000, DRIP)

YearMDCA PortfolioMDCA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$19,150$8,450.18$10,594$274.49+$8.6KMDCA
2$35,614$15,123.60$11,294$360.69+$24.3KMDCA
3$64,393$26,285.90$12,133$476.91+$52.3KMDCA
4$113,318$44,417.57$13,156$635.42+$100.2KMDCA
5$194,302$73,051.82$14,432$854.61+$179.9KMDCA
6$324,968$117,064.54$16,056$1,162.76+$308.9KMDCA
7$530,696$182,980.23$18,175$1,604.53+$512.5KMDCA
8$847,116$279,270.81$21,009$2,252.68+$826.1KMDCA
9$1,323,032$416,618.52$24,911$3,229.73+$1.30MMDCA
10$2,023,755$608,110.53$30,458$4,749.88+$1.99MMDCA

MDCA vs JNJ: Complete Analysis 2026

MDCAStock

MDC Partners Inc. provides marketing, advertising, activation, communications, and strategic consulting solutions worldwide. It offers a range of client services, including global advertising and marketing, data analytics and insights, mobile and technology experiences, direct marketing, database and customer relationship management, business consulting, sales promotion, corporate communications, market research, corporate identity, design and branding services, social media strategy and communications, product and service innovation, and e-commerce management, as well as media buying, planning, and optimization. The company was formerly known as MDC Corporation Inc. and changed its name to MDC Partners Inc. in January 2004. MDC Partners Inc. was founded in 1980 and is headquartered in New York, New York.

Full MDCA Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this MDCA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDCA vs SCHDMDCA vs JEPIMDCA vs OMDCA vs KOMDCA vs MAINMDCA vs ABBVMDCA vs MRKMDCA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.